Express Scripts Wants Class Bid Cut In Acthar Case
Express Scripts and its subsidiaries asked an Illinois federal judge Monday not to certify a class of customers bringing antitrust allegations over sales of the anti-seizure drug Acthar, saying it doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article